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Summary
Although previous studies using human cytokines in rabbits and rats have provided evidence
ofthe participation oftumor necrosis factor a (TNF-(x) and interleukin lß (IL1ß) in the meningeal
inflammatory cascade, the results obtained by several groups ofinvestigators have been discordant
or, at times, contradictory. In the present study, homologous cytokines were applied to the rabbit
meningitis model. Intracisternal administration of 102-101 IU of purified rabbit TNF-a
(RaTNF-a) produced significant cerebrospinal fluid (CSF) inflammation. A similar response was
observed after intracisternal inoculation of 5-200 ng of rabbit recombinant ILlß (rrIL1ß).
Preincubation of these two mediators with their specific antibodies resulted in an almost complete
suppression of the CSF inflammatory response. In animals with Haemophilus influenzae type b lipo-
oligosaccharide-induced meningitis, intracisternal administration of anti-rrlIrlß, anti-RaTNF-a,
or both resulted in a significant modulation of meningeal inflammation. Simultaneous administration
of 103 IU of RaTNF-a and 5 ng of rrILlß resulted in a synergistic inflammatory response
manifested by a more rapid and significantly increased influx of white blood cells into the CSF
compared with results after each cytokine given alone. These data provide evidence for a seminal
role of TNF-a and IL1ß in the initial events of meningeal inflammation.
D espite the availability ofadvanced medical intensive care
and of extraordinarily active antibiotics for treatment
of bacterial meningitis, the case fatality and long-term mor-
bidity rates associated with this disease have not appreciably
changed (1, 2). As a result, research designed to delineate
the molecular pathophysiology ofthis condition has focused
on the mechanisms responsible for the inflammatory response
in the subarachnoid space. Initial attention was focused on
the specific components of the pneumococcal cell wall (3,
4) and the lipooligosaccharide of Haemophilus infiuenzae type
b (Hib)' (5, 6), and on their ability to elicit inflammation
in the cerebrospinal fluid (CSF) and to alterblood-brain bar-
rier permeability (7, 8).
Two cytokines, TNF-a (cachectin) and ILl, were shown
to play a seminal role in the host's response to these bacterial
1 Abbreviations used in this paper., ANOVA, analysis of variance; CSF,
cerebrospinal fluid; Hib, Haemophilus influenzae type b; ILli, 11A
inhibitor; LOS, lipooligosaccharide; RaTNF-a, rabbit TNF-a; rr11,
lß, rabbit recombinant IL10; WBC, white blood cell.
elements (9-13). Although the monocyte/macrophage is the
principal source ofIL1 and TNF-a, other cells have also been
shown to produce these cytokines. Of relevance to menin-
gitis, astrocytes and microglial cells produce ILl and TNF-a
within the central nervous system (14-17). These mediators
have been detected in CSF of patients with bacterial menin-
gitis caused by Gram-positive and Gram-negative organisms
(18-23), and in CSF of animals experimentallyinoculated with
Hib, N. meningitidis, Hib lipooligosaccharide (LOS), and pneu-
mococcal cell wall fragments (18, 22, 24-26). Additionally,
the availability of rTNF-a and IL1f, as well as specific anti-
bodies directed against these molecules, has permitted con-
trolled investigations of their role in the meningeal inflam-
matory cascade. Experiments in which animals were
intracisternally inoculated with these cytokines, and in which
anticytokine antibodies were utilized to attenuate the inflam-
matory response induced by different bacteria or their com-
ponents, have provided substantial evidence of their partici-
pation in this process (24, 27, 28). Results obtained by several
groups of investigators, however, do not coincide and, at times,
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methodology or in the source of cytokines used in those ex-
periments. Use of human cytokines and their specific anti-
bodies in the rabbit and rat models could explain, at least
in part, thesediscrepancies. Although the amino acid sequence
of thesecytokines is highly conserved among various species
(9, 12), differences in the molecular conformation associated
with different epitopes and/or with therepertoire ofbiolog-
ical activities (29), and the species-specific nature of the
receptor-ligand interaction ofTNF-a (30), couldaccount for
the dissimilar results observed.
The use of homologous preparations in these animals
systemswas recently suggested (28) as ameansof determining
the precise roles of and relationships among thesecytokines
in the meningealinflammatory pathway. Rabbit recombinant
IIr1f3 (rrllr10) (31, 32) andpurified rabbit TNF-ca (RaTNFLot)
(33, 34) were recently made available to us. These molecules
and their specific antibodies were applied to the traditional
rabbit meningitis model (35) in an attemptto delineate these
complex interactions.
Materials and Methods
Preparation of Hib LOS.
￿
LOS was purified from cells of Hib
strain DL42 by using the hot phenol-water method of Westphal
andJann (36), as modified byJohnson and Perry (37). The purity
of this LOS preparation was confirmed by SDS-PAGE, followed
by silver staining (38) and Western blot analysis using hyperim-
mune rat serum to Hib DL42 (39).
It waspreviously shown that HibLOSin either itspurified form
or as an integral part ofthe outermembrane of Hib, when injected
intracisternally, inducedmeningeal inflammation and alteration of
blood-brain barrier permeability (5-8). The minimal amount of
LOS necessaryto induce CSFpleocytosis was0.02ng. Intracisternal
injection of 20 ng of Hib LOS, an amount equivalent to 2 x 10,
cells, consistently induced substantial changes in the indices of
meningeal inflammation (5). Because CSF samples from patients
with Hib meningitis contain from 10° to 10' CFU/ml, 20 ng of
HibLOSwaschosen as an appropriate inoculum to induce menin-
gitis in our studies.
BacterialStrain.
￿
Hibstrain DL42 is anon-0-lactamase-producing
strain isolated from theCSFofachildwith meningitis. This strain
hasbeen shownto be virulent in the infant ratmodel forHibinva-
sive disease andto belong to LOSantigenicgroup 2, whichis the
predominate LOSantigenic type among invasive Hib strains (40).
rrIL1S.
￿
rrID10 waspurified from the extract ofEscherichia coli
(HB 101) that was transformed with a rabbit 11,10-containing
plasmid. Thepurification was performedby gelfiltration, C9 treat-
ment for endotoxin removal, and HPLC on IEX 530 KS (silica-
CM type; 7.8 mm x 30 cm; Toso Co. Ltd., Tokyo). Theresulting
material was confirmed to show a single band on SDS-PAGE and
to have a single amino acid terminus, Ala, andwas thought to be
composed of 152 amino acid residues. The activity of this material
is 1 U/20 pg, as estimated by thymocyte comitogenic assay. Be-
causethe endotoxin content of this compound tested in achromo-
genic Limulus assaywas 10 pg/Ftg, the maximumdose ofrri1r1(3
(200 ng), injected intracisternally, containedonly 2pg ofendotoxin.
Anti-rrlblo Serum.
￿
The anti-rrID10 serum was obtained by
immunizing a goat for 8 mo with rrIIr10 with CFA. This serum
neutralized 2 U (40 pg) of rrIIA0 at a dilution of 2-1^. The serum
wasdiluted 1:100 forintracisternal injections in rabbits.Theendo-
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toxin content of this dilution measured by thechromogenic Limulus
assay was 7 pg/ml. Intracisternal injections of 0.1-0.2 ml of the
diluted antiserum didnotinduce significant CSFpleocytosis (max-
imum 30 white blood cells (WBC)/mm3).
IM Inhibitor(Mli).
￿
This IM inhibitor is a 22-kD molecule
present in the supernatant of human monocytes cultured on ad-
herent immune complexes. It blocks Ih1 augmentation of PHA-
inducedmurine thymocyteproliferation, butnot IIA-induced stim-
ulation of CTLL or HT -2 cell lines. It specifically blocks binding
of IL1 to its receptor on the murine thymoma cell line ELA6.1.
Westernblot analysis showed no immunological crossreactivity be-
tween IIA andthis IIAi (41). Thecompound was kindly provided
by Synergen (Boulder, CO).
Rabbit TNFa(RATNFot).
￿
Naturalrabbit TNF-apurified from
sera of rabbits treated with Propionibacterium acnes and endotoxin
(33) waskindly suppliedby DainipponPharmaceutical Co. (Osaka,
Japan). The activity of the preparation is 8 x 106 IU/ml. It con-
tained 0.80ng/ml ofendotoxin, as measured by thechromogenic
Limulus assay. In our experiments, we inoculated up to 101 IU
of RaTNF-a that contained 10 pg of endotoxin.
Anti-RQTNFct.
￿
Ascitic fluid from BALE/c mice with hybrid-
oma-secreting monoclonal anti-RaTNF-a (IgGI) (33) wasused as
a source ofanti-RaTNF-a. A 1:100 dilution ofascitic fluid neutral-
ized an equalvolume of RaTNF-awith an activity of 11,200 IU/ml
in the L929 cytotoxicity assay (34). Theendotoxin content of this
ascitic fluid preparation was 80 pg/ml. Intracisternal inoculation
of rabbits with 50 Al of the original product diluted in 200 F.1 of
pyrogen-free saline did not induce CSF inflammation.
Cytolytic AssayforTNFa.
￿
TNF-a activity was determined by
modification ofapreviously describedcytotoxic assay(42). Briefly,
L929 cells (CCL 1; America Type Culture Collection, Rockville,
MD)were maintained in DME supplemented with 10% FCS and
4% penicillin and streptomycin. Confluent cultures were rinsed
with sterile PBS, then brieflywith 0.05% trypsin, resuspended in
fresh medium, and added to 96-well plates (7 x 101 cells/well).
After 2-3 h in culture, 50 Al of cycloheximide (0.3 mg/ml) and
5 IA1of CSF sampleswere added to each well, and the plates were
incubated overnight (5% CO2, 37°C). After microscopic evalua-
tion, themedium was decanted, and thewellswere filled with 100
Al of0.5% crystalviolet in 25% methanolfor5min, washed thor-
oughly with normal saline, anddried.Thedyewas solubilized with
100 itl of 50% acetic acid. The degree of cytotoxicity wasquantified
spectrophotometrically (490 nm)usingacomputerized automated
ELISAplatereader (3550;Bio-RadLaboratories, Richmond, CA).
Equivalent concentrations of rabbit TNF-a were determined for
experimental samples by interpolation of the RaTNF-a standard
curve run simultaneously (10-1 to 101 IU/ml). Using this assay,
we couldreliably detect as little as 5 IU/mlof rabbit TNF-a. The
samples were assayed in quadruplicate, and a SD within 10% of
the mean was observed.
Detection of ILI0.
￿
Rabbit 1140 was measured by an ELISA
developed in Kumamoto University (Japan). In brief, microtiter
plates (Immunoplate MaxiSorp F96; Nunc, Kamstrup, Denmark)
were coated overnight at 4°C with 100 14 of goat IgG antibodies
directed against rabbit 11,10 diluted in a 10-lag/ml concentration
in0.1 M sodium carbonatebuffer (pH9.6).Theplates were washed
five times with PBSTween 20 (0.05%) andthen blockedovernight
at 4°Cwith carbonatebuffer containing 1% BSA. Afterfive washes,
100 p,l of rabbit CSF was incubated at 4°C overnight, the plates
were again washed, and then coated with biotinylated goat anti-
rabbit 11,10IgG (5 lzg/ml) in PBSTween20 containing 0.1% BSA.
Aftera3-hincubation at room temperature, theplates were washed,
a 100-Fl volume of avidin-peroxidase (Vector Laboratories,Burlin-game, CA) wasadded, as recommendedby themanufacturer, and
theplates were incubatedfor90 min at room temperatureand then
washed. A 100-A.1 volume of O-phenylen diamine (0.8 mg/ml) in
0.1 M citrate buffer (pH 5.0) containing 0.03% H202 was added.
After 40 min in room temperature, the OD (492 nm) was mea-
suredby an ELISA reader (3550; Bio-Rad Laboratories). Thecon-
centrations ofrabbit IDI# in test sampleswere obtained by com-
parison with the knownconcentrations (30-300 ng/ml) ofrrID10.
This standard was used on each microtiter plate. The lower limit
of detection of this assay was 30 pg/ml.
Measurement ofCSFLactate andProtein.
￿
CSF sampleswere ana-
lyzed for lactate with a kinetic enzymatic method that used the
reaction of lactate with Nicotinamide-adenine dinucleotide (0-
NAD+) in the presence of lactate dehydrogenase to produce Nico-
tinamide-adeninedinucleotide, reduced (NADH) andpyruvate. The
production ofNADH was quantitatively determined at a 340-nm
absorbance on a spectrophotometer (3600; Gilford, Oberlin, OH)
with a deuterium source. Theprecision of themethod was tested
by runningaknownstandard of40 mg/dl(UVtest 826-UV; Sigma
Chemical Co., St. Louis, MO) 10 times in 1 d. The coefficient
of variation was 2.2%.
Protein concentrations were measured by amodified biuret assay
on the Ektachem 700 (Kodak, Rochester, NY). In this method,
protein in amoderately alkaline solution chelates Cue* ions from
an azo dye, resultingin a spectral shift. Thedecrease in absorbance
of the copper-azo dye complex is related to the concentration of
protein in thesample. This method detects albuminandglobulins.
In Hib LOS-induced meningitis, intracisternal inoculation of
anti-RaTNF-a antibody caused asignificant earlyelevationofCSF
protein concentration that interfered with measurement of this index
ofmeningealinflammation. As a result, this variable could not be
analyzed in that set of experiments.
ExperimentalMeningitis Model.
￿
Therabbit modelofexperimental
meningitis, originally describedby DaceyandSande(35), was used
in a modified form. Approximately 400New Zealand white male
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rabbits (2-3 kg) were anesthetized with intramuscular injections
of ketamine (40 mg/kg) and acepromazine (3 mg/kg) andplaced
in a stereotactic frame. A spinal needle was introduced into the
cisterna magna and0.2-0.3 ml of CSF withdrawn. Animals were
then inoculated intracisternally with thedifferent test materials in
a total volume of 0.2-0.3 ml. Subsequent CSF samples (0.2 ml)
were obtained at 1 (incertain experiments this sample wasnot ob-
tained to avoid potential removal of the cytokine), 2, 4, 8, 12, 24
and sometimes at 48 h. Immediately after collection, the CSF ali-
quots were analyzed for cell count using a Neuber hematocytom-
eter (American Optical, Buffalo, NY). The remaining CSF was
centrifuged at 5,000 rpm for 5 min, and the supernatants were
stored at -70°C until assayed forlactate, protein, and cytokknns
concentrations.
Statistical Analysis.
￿
Two-wayrepeated measures analysis of vari-
ance (ANOVA) wasused to assess the effect of independent treat-
ments with time for the following variables: WBC, protein, and
lactateconcentrations in the CSF. Values ofeach variable obtained
at four or five different time points were included in the analysis.
In Hib LOS-induced meningitis experiments, peak CSF TNF
activity among different treatment groups was analyzed by the
MannWhitney U Test.
All data are expressed as mean ± SEM, unless otherwise indi-
cated. p values <0.05 were considered significant.
Results
Inoculation ofrrlL1o.
￿
Intracisternal injections of 5-200 ng
of rrIIrl0 was associated with significant CSF pleocytosis
that increased in a dose-dependent fashion up to a 100-ng
dose (Fig. 1). When 200 ng of rrIL10 was administered
intracisternally, the CSF WBC counts observed were com-
parable with those seen after 100-ng injections. 500 pg of
11 *-n
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Figure 1. CSF WBC response after varying
intracisternal doses of rrIL10. Time represents
hours after inoculation.rrIIr1O did not produce significant pleocytosis. The specificity
of this inflammatory response was evaluated in two sets of
experiments.
Preincubation of 200 ng of rrIIAO with 100 tcl of 1:100
dilution ofanti-rrIIAO serum resulted in an almost complete
suppression of meningeal inflammation, as evidenced by
WBC, protein, and lactate concentrations in CSF (Fig. 2,
A and B) .
Intracisternal administration of 200 ng of rrIL10 with a
specific ILE (1 mg/kg) yielded a significant reduction of CSF
pleocytosis (Fig. 3).
The time pattern of these inflammatory changes induced
by rrIIr10 was substantially delayed compared with those in-
duced by intracisternal inoculation ofpurified Hib LOS. CSF
WBC counts peaked between 6 and 12 h after intracisternal
A 6,000
5,000
4,000
"- "rr IL 1B, 200 ng
-
￿
0--- -0rrIL18,200ng+anti -IL1B
injection of Hib LOS, compared with 12-24 h in animals
injected with rrIIr1a (Fig. 4) . In contrast to the response
after Hib LOS, no TNF-ci activity was detected in CSF of
animals with rrllrlo-induced meningeal inflammation (Fig. 4) .
Measurement ofRabbit ILI# in CSR
￿
CSF rIIAO concentra-
tions, when measured by ELISA, were consistently low (range,
<30-216 pg/ml) during the 24 h after LOS injections. The
largest values were usually observed 6-12 h after intracisternal
inoculation with Hib LOS, however, no consistent peaks were
detected. Because the rIIr10 concentrations were unexpect-
edly low, 36 split CSF samples were independently tested
by RIA (43) by Dr. Charles Dinarello, (New England Med-
ical Center, Tufts University School ofMedicine, Boston, MA).
Those results were similar to the values obtained by ELISA,
with no consistent peak concentrations and a rangebetween
30 o)
E
am
Iii
E
B 50
500
￿
Cytokines in Meningeal inflammation
40
10
90
80
70
60
c 50
0
ti 40
30
20
10
"- " rr IL 1 B, 200 ng
0----OrrIL1B,200ng+anti-IL1B
p<0.001
(Anova)
p=0.015
(Anova)
2
￿
6 9 12
￿
24 8
Time (hours)
i
￿
I
2
￿
6 9 12
￿
24 8
Time (hours)
Figure 2 .
￿
Effect of anti-rrIL10 on rrIL10-induced meningitis in rabbits. (A) Effect on CSF WBC counts. (B) Effect on lactate and protein
concentrations in CSRE
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Figure 3.
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Effect of IL1i on rrILl/3-induced pleocytosis.
56 and 230pg/ml. Similarly, in rabbits with bacterial menin-
gitis induced by 2 x 104 to 2 x 106 Hib organisms, CSF
rIL10 concentrations were from <30 pg/ml before, to 352
pg/ml at 6 h after inoculation.
Inoculation ofRaTNF
￿
Intracisternal inoculation of 102 to
105 IU of RaTNF-a was associated with significant CSF
pleocytosis. As was observed with rrIL10, CSF WBC counts
increased in parallel with increments in RaTNF-cY dose, but
no significant differences in CSF PMN concentrations were
documented after 104 or 105 IU of RaTNF-a injections (Fig.
5). The timing of the WBC response in CSF after inocula-
tion of RHNF-a was comparable with that seen after rrIL
10, with peak values observed between 12 and 24 h, and per-
sisting pleocytosis for up to 48 h.
Preincubation of 104 IU of RaTNF-a with 50 Fd of ascitic
fluid containing specific anti-RaTNF-a mAb produced modu-
lation of the inflammatory response induced by RaTNF-a.
This was manifested by significantly lowerWBC, protein, and
lactate concentrations in CSF afterinoculation of RaTNF-a
and anti-RaTNF-a, compared with RaTNFa alone (Fig. 6,
A and B) .
CSF rIL10 concentrations were from <30 pg/ml before,
to 292 pg/ml after inoculation of RaTNF-ac; although low
values were found, all animals had detectableamounts of rIL10
in CSF after intracisternal administration of RaTNF-a.
Effect ofAnti-rdL10 andAnti-RaTNRa on Hib LOS-induced
Meningitis. The effect of anti-rrIL10 and anti-RaTNF-at on
Hib LOS-induced meningeal inflammation was assessed in
groups of rabbits that received the following intracisternally:
(a) 20 ng of Hib LOS + 100 Al (1:100 dilution) of anti-rrIL
10; (b) 20 ng of Hib LOS + 50 Al of anti-RaTNFa; (c) 20
501
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￿
CSF WBC and CSF TNF-oi activity after intracisternal
inoculation of Hib LOS or rr1L1o.
ng of Hib LOS + 100 Al of anti-rrIL1ilj + 50 Al of anti-
RaTNFa; or (d) 20 ng of Hib LOS alone (controls).
In all experiments, the volume of these combinations in-
jected intracisternally was adjusted with pyrogen-free saline
to 0.3 ml.
All three treatment regimens (anti-rrIL110, anti-RaTNF-a,
and anti-rdL1o + anti-RaTNF-a) had a significant modula-
tory effect on CSF WBC and lactate concentrations (Fig. 7,
Table 1). The most marked attenuation of CSF inflamma-
tion was observed in the rabbits treated with both anti-rrIIr
10 and anti-RaTNF-a.
CSF TNF-a activity in the two groups of animals that
received anti-RHNF-a (either alone or in combination with
anti-rrIL10) was almost completely suppressed (Fig. 7) . Al-
though the meningeal inflammatory response in rabbits treated
with anti-rrIL19 alone was also significantly reduced at 2
and 6 h, their TNF-a activity in CSF was similar to that
of animals given Hib LOS alone.
Combined effect ofrriIL10 and RaTNF-a.
￿
In this set of ex-
periments four groups of rabbits were inoculated intracister-
nally with one ofthe following regimens: (a) rrIL1# (5 ng);
(b) MNF-at (103 IU); or (c) rrILl0 (5 ng) + RaTNF-a
(103 IU) .
Simultaneous administration of 103 IU of RaTNF-a and
5 ng ofrrILlit3 resulted in a synergistic inflammatory response
manifested by a more rapid and significantly increased influxA 3000
E 2000
E
U
m
3
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Figure 5.
￿
CSF WBC response after varying intracisternal doses of
RaTNF-a. Time represents hours after inoculation.
of PMNs into the CSF, compared with each cytokine given
alone (Fig. 8) . The response to both cytokines was similar
to that observed after inoculation of 20 ng Hib LOS. The
CSF protein concentrations were significantly larger in rabbits
treated with rrIIr10 + RaTNF-ci than in those given either
RaTNF-ci or rrl1r1O alone (Table 2) . By contrast, CSF lac-
tate concentrations were similar in animals injected with
RaTNF-oi + rrILr10, and in those inoculated with rrIIAO
alone, and both groups had values significantly larger than
animals that received RaTNF-ci alone (Table 2).
E$ectofAnti-RaTNF-ac on rrII l S-induced Meningitis and of
Anti-rdl,l/3 on RaTNF-cli-induced Meningitis. The aim ofthese
experiments was to assess the effect of each antibody on the
0-8 Ra TNFa (10° IU)
O- -O Ra TNFa+ anti-Ra TNFa
Pc 0.0001
(ANOVA)
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CSF inflammatory response generated by the other cytokine.
Groups of rabbits were injected intracisternally with the fol-
lowing regimens: (a) rrI1r1I0 (200 ng); (b) rrI1rls (200 ng)
+ anti-RaTNF-rx (50 ul); (c) RaTNF-a (104 1U); or (d)
RaTNF-tat (104 IU) + anti-rrllrlo (100 Wl; 1:100 dilution).
Neither antibody exerted a significant modulatory effect
on the CSF WBC response induced by the other cytokine
(Table 3).
Discussion
Both homologous cytokines, RaTNF-cx and rrIIr10, when
inoculated directly into the subarachnoid space, induced menin-
geal inflammation in the rabbit meningitis model. The al-
most complete suppression of the CSF inflammatory changes
observed when these cytokines were administered with their
respective antibodies demonstrated the specificity of this
inflammatory response.
The dose-ranging experiments with rrllrlo and RaTNF-ci
indicated that CSF pleocytosis increased in parallel to incre-
ments in cytokine dose, but only to a limited extent. CSF
WBC counts generated after intracisternal inoculation of 104
or 105 IU of RaTNF-a were comparable, as were the counts
measured after animals were injected with 100 or 200 ng of
rrIlr10. An analogous dose-limited response was previously
observed when purified Hib LOS (5, 7) or Hib OMV (6,
8) were given intracisternally to rabbits or rats. The latter
dose-limited inflammatory reactions are likely a reflection of
the close interaction of the bacterial components and these
two cytokines in the initial stepsof meningeal inflammation.
10 ng (5 ng/kg) ofrrllr1a was required to induce significant
and consistent CSF pleocytosis (CSF WBC >1,000/mm3)
in our model, the same quantity of rrIIr10 that was shown
to be necessary to elicit a febrile response when injected in-
travenously into rabbits (43). Likewise, Kawasaki et al. (34)
described recently that 3 x 102 to 3 x 103 IU/kg of
-E Ra TNFa
0...-O Ra TNFa, +anti-Ra TNFa
p= 0.042
0 2 4
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Figure 6.
￿
Effect of anti-RaTNF-a
on RaTNF-a-induced meningitis
in rabbits. (A) Effect on CSF
WBC counts. (B) Effect on lactate
and protein concentrations in CSRE
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Figure 7.
￿
Modulatory effect of anticytokine antibodies on CSF
WBC counts (top) and on CSF TNF activity (bottom) during Hib
LOS-induced meningitis. In CSF WBC counts, p = 0.018
(ANOVA, over time) in LOS alone (A) vs. LOS + anti-rrIL-10 (");
p = 0.026 in LOS alone (A) vs. LOS + anti-RaTNF-a (N); and
p = 0.0023 in LOS alone (A) vs. LOS + anti-rrIL-10 + anti-
RaTNF-a (O). In CSF peak TNF activity (at 2 h), p = 0.027
(Mann-Whitney U) in LOS alone (A) vs. LOS + anti-RaTNF-a
(/); and p = 0.029 in LOS alone (A) vs. LOS + anti-RaTNF-a +
anti-rrIL10 (O); p = 0.114 in LOS alone (A) vs. LOS + anti-rrIL
1S ("); and p = 0.869 in LOS + anti-RaTNF-a (N) vs. LOS +
anti-RaTNF-a + anti-rrIL1/3 (O).
RaTNF-a evoked a monophasic febrile response, and that 3
x 104 IUlkg was required to produce a biphasic febrile reac-
tion. In our experiments, significant and consistent CSF
pleocytosis was attained after intracisternal inoculation of
-104 IU of the same preparation. It is remarkable that these
Table 1.
￿
Elect of Anticytokyne Antibodies on CSF Lactate Concentrations in Animals with Hib LOS-induced Meningitis
Doses: Hib LOS: 20 ng; anti-rrIL-1/3, 100 ,tcl of 1 :100 dilution; anti-RaTNF-a, 50 ul.
" Lactate expressed as mean ± SEM.
t p = 0.04 (ANOVA, over time) when compared with LOS alone.
S p - 0.0034, when compared with LOS alone.
11 p = 0.0001, when compared with LOS alone.
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24
cytokines possess a similar threshold for fever induction and
initiation of meningeal inflammation in the rabbit.
The uniformly delayed appearance of PMNs in the CSF
ofrabbits with rrIL1,Q- or RaTNF-a-induced meningitis com-
pared with results in Hib LOS-induced meningitis was un-
expected. These findings contrast with those usingcytokines
of human origin in the rabbit and rat models (27, 28), which
demonstrated a faster response. However, when low doses
of rrIL10 and RaTNF-a were given concomitantly, a
significant synergistic effect in provoking a more rapid and
increased migration of leukocytes into the CSF was observed.
The time pattern of this response was similar to that demon-
strated in rabbits after intracisternal inoculation of Hib LOS
(Fig. 8). We believe these findings suggest that each of these
two cytokines, rrIL10 and RaTNF-a, alone is capable ofini-
tiating the sequence of events that leads to meningeal inflam-
mation. The participation ofboth cytokines appears to occur
in vivo after bacteria reach the subarachnoid space in natu-
rally occurring bacterial meningitis, or after Hib LOS is in-
troduced intracisternally.
Additional evidence for the required involvement ofboth
cytokines is provided by the experiments in which anti-rrIL
10 and anti-RaTNF-a were utilized to modulate Hib LOS-in-
duced meningeal inflammation. Each antibody inoculated
separately or together with Hib LOS exerted a significant
modulatory action at 2 and 6 h. Elimination of CSF TNF-a
activity was not a prerequisite to attenuate inflammation, as
shown by the experiments in which LOS and anti-rrILl(3
were given. The modulatory effect of these antibodies lasted
for at least 6 h, and was not observed at 12-14 h after inocu-
lation. This is likely explained by binding of the antibodies
to their respective cytokines and their subsequent elimina-
tion from the subarachnoid space in the presence of LOS that
can be measured in CSF for at least 12 h after inoculation
(unpublished observations). We did not give repeated doses
of antibody in these experiments.
Despite the use ofamounts ofantibody known to be effec-
tive in reducing Hib LOS-associated inflammation and in sup-
Inoculated material(s) 0 h 2h
CSF Lactate concentrations
6h
at:
12h 24h
mg/dl
LOS alone 19.0 ± 1 .0` 27.5 ± 1 .7 37.5±2.6 38 .0±2.6 25.6±2 .1
LOS + anti-rrIL-10 15 .8 ± 0.6 19.3 ± 1 .7 38.0 ± 5.6 34.2 ± 2.6 23.2 t 0.7t
LOS + anti-RaTNF-a 13 .7 ± 0.8 17 .0 ± 1 .9 28.4 ± 7.3 36.6 ± 3.1 20.9 ± 2,2s
LOS + anti-rrIL-10 + anti-RaTNF-a 14.5 ± 1 .6 16 .3 ± 1.7 21.7±3.0 33.2±4.5 20.0±1 .211E
E
U
m
3
U
IC Inoculation
&---A Hib LOS (20 ng)
w-w Ra TNFa + rr IL 1[i
0-0 Ra TNFa(103 IU)
o----O rr IL 1p (5ng)
Figure 8.
￿
CSF WBC counts after intracisternal inoculation with
RaTNF-a, rrIL10, or RaTNF-a and rrIL113. CSF WBC counts for
the Hib LOS group represent the mean values of eight rabbits evalu-
ated throughout the study. p < 0.0001 (ANOVA, over time) in
RaTNF-a + rrILl/3 (/) vs. RaTNF-a alone (EI), and vs. rrlL10
alone (O).
pressing the effect of its respective cytokine, we were sur-
prised that there was no inhibitory action of anti-rrIL10 on
RaTNF-a-induced meningitis and of anti-RaTNF-ca on rrIL
1(3-induced meningitis. This observation emphasizes again
that both cytokines are capable of independently initiating
4 p = 0.0085 (ANOVA, over time), when compared with rrIL-10 alone; and p = 0.0016 when compared with RaTNF-a alone.
5 p < 0.001 (ANOVA, over time), when compared with RaTNF-a alone; and p = 0.992 when compared with rrIL-10 alone.
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Table 3.
￿
CSF WBC Counts after Intracisternal Inoculations
with Various Cytokines and Anticytokine Antibodies
* CSF WBC per mm3 as mean ± SEM.
4 ANOVA over time, p = 0.419.
5 ANOVA over time, p = 0.839.
events that lead to meningeal inflammation. Although nei-
ther cytokine is dependent on the presence of the other
for inflammatory activity, when combined, they act syner-
gistically.
Our results confirm, in part, and extend observations based
primarily on the use of recombinant human molecules in the
rat and rabbit models. The actual role of TNF-a in menin-
geal inflammation has been debated. We showed previously
that TNF-a is detected in the CSF of rabbits injected in-
tracisternally with Hib LOS, and that the peak concentra-
tion of TNF-a at 2 h after inoculation precedes the appear-
ance ofPMNs in CSF (24). In addition, a significant correlation
Table 2. Combined Efect of rrIL-I,# and RaTNF-a on Protein and Lactate Concentrations in CSF
Inoculated material(s) 0 h 2 h
CSF protein concentrations
4h 8h 12h 24 It
mg/dl
rrIL-10 (5 ng) 26.2 ± 3 .7' 33 .7 ± 9.4 30.5±12.0 22.2±4.9 41 .2±7 40.0±2.1
RaTNF-a (103 IU) 26.2 ± 1 .1 26.7 ± 4.9 23.5±2.3 36.0±9.9 49.3±6.7 34.2±5.2
rrIL-10 + RaTNF-ca 26.7 ± 0 .7 38.2 ± 12.7 45.2 ± 14.9 32.0 ± 7.3 76.7 ± 11 46.2 ± 15 .54
CSF lactate concentrations
0h 2h 4h 8h 12 It 24h
mg/dl
rrIL-10 (5 ng) 21.3 ± 1 .9" 15 .6 ± 0.7 21.3 ± 1 .5 29.3 ± 1.9 49 .4 ± 2.3 32.2 t 3.8
RaTNF-a (103 IU) 18.2 ± 0 .8 14.9 ± 0.7 17.4 ± 0 .9 18.2 ± 0.6 28 .2 ± 1.9 32.2 ± 5.2
rrIL-10 + RaTNF-ca 18.8 ± 0.9 17.1 ± 1 24.1±1 .6 28.4±1.1 47.4±2.3 33.2±3.7s
" Mean ± SEM.
Inoculated
material(s) 6 h
CSF
12
WBC
h
at:
24 h
rrIL-10 195 ± 63" 3,312 ± 926 2,875 ± 1,0814
rrIL-ifl +
anti-RaTNF-a 135 ± 52 1,800 ± 531 3,100 ± 6014
RaTNF-ac 92 ± 33 1,480 ± 713 1,725 ± 3255
RaTNF-a +
anti-rrIL-10 77 ± 42 1,525 ± 280 1,525 ± 1895between CSF TNF-ci concentrations and the CSF inflam-
matory indices was demonstrated, and more importantly, in-
tracisternal administration of a polyclonal antibody to recom-
binant humanTNF-a (rhTNF-ot) in LOS-induced meningitis
caused a significant attenuation of the CSF inflammatory re-
sponse (24). However, rhTNF-ot failed to induce CSF pleocy-
tosis and increased blood-brain barrier permeability when
tested in the rat model (44), and we were unable to induce
meningeal inflammation afterintracisternal inoculation of up
to 150 wg of rhTNF-ot (unpublished observations). By con-
trast, Saukkonen et al. (28), using rhTNF-ci in rabbits, ob-
served a marked inflammatory response with a dose of 104
IU. The discrepancies between their results and ours might
be explained by differences in preparation and storage of the
rhTNF-cx. We believe that the present data, usingthe natural
rabbit molecule of RaTNF-a, establish clearly a prominent
role of TNF-ci in the inflammatory cascade.
Two biochemically distinct but structurally related 1Ir1 mol-
ecules (IL1a and IL1R) have been cloned in humans (12) and
also in rabbits (32, 43). There is only 26% amino acid ho-
mology between humanILla (hIL1a) and humanIL1/3 (hIL-
1/3), whereas there is 74% homology between hIL1(3 and
rIL1/3. Receptors recognize a and (3 forms, and both are
thought to have similar biological effects. mRNA coding for
IL1R predominates over that coding for IL1a (12, 43) . This
prevalence is also observed when molecules are measured in
body fluids. It is believed that IL10 acts as a soluble medi-
ator, whereas IL1a remains mostly cell associated (45).
The low rILla concentrations detected by the ELISA system
in CSF of rabbits with LOS-induced meningitis or after in-
tracisternal inoculation of Hib bacteria contrast with the values
previously reported by Wispelwey et al. (25), using a bio-
assay on D10.G.41 cells. They found 10-20 times larger values
with a clear peak of activity at 30 min post-inoculation, a
kinetic response similar to that demonstrated previously with
TNF-ci (24). Likewise, Waageet al. (22),by means of a two-
step assay on T cell lines NOB and HT2, reported peak CSF
ID10 concentrations of 600 pg/ml (two to three times our
levels), 2 h after the TNF-ci peak and 4 h after intracisternal
injection with 500 ng ofmeningococcal LPS. The discrepancy
between our data and those ofWispelwey et al. (25) and Waage
et al. (22) prompted us to verify our results. Split CSF samples
were sent to Charles Dinarellds laboratory, who, using a
specific RIA for rIIr10 and a different polyclonal antibody
to rrIL1(3 (43), confirmed our findings that the concentra-
tions of rIL1(3 in CSF ofour animals were low and that there
were no clear peak values. The bioassays used by Wispelwey
et al. (25) and Waage et al. (22) measured total IL-1 activity,
which included IIAoi and IL10, whereas the ELISA and RIA
systems detected only the immunoreactive rIL1a, which based
on the available information in the rabbit, was expected to
be the predominant form (43). Additional studies are required
to resolve this discrepancy.
The results with the rabbit recombinant preparation sub-
stantiated the important participation of 1140 in meningitis.
Earlier studies by Quagliarello et al. (27), in the rat model,
demonstrated that hrIL10 induced increased blood-brain bar-
rier permeability and CSF pleocytosis. The same molecule
(hrIL1o), however, did not provoke a significant response
in rabbits (28), but a very marked inflammatory reaction was
seen after injectionswith hrlWot. The homologouscytokine,
rrIL1/3, elicited a clear inflammatory response in this rabbit
model, and its specific antibody, anti-rrIL1o, attenuated Hib
LOS-induced meningeal inflammation.
Another facet of the complex interactions of IL1O and
TNF-ci is the capacity of each cytokine to stimulate produc-
tion of the other. Using a very sensitive cytolytic assay, we
could not detect any CSF TNF-ci activity in rabbits with
rrIL1/3-induced meningitis. By contrast, rIL1(3 was present
in low concentrations in CSF of animals with RaTNF-oi-
induced meningitis. This confirms previous in vitro studies
by Dinarello et al. (46), in which TNF-at elicited IL1 produc-
tion from human mononuclear cells. Recently, Fong et al.
(47) demonstrated that passive immunization against TNF-cx
reduced the appearance of IL1(3 and IL-6 in experimental le-
thal bacteremia.
Further studies will be required to elucidate the intricate
interactions of TNF-a and IL10 and other cytokines, such
as 11,6 (22), MIP-1, and MIP-2 (28) in the meningeal inflam-
matory cascade. The activities of these mediators on cerebral
capillary endothelial cells (i.e., blood-brain barrier) (48) and
the role of specific cytokine and receptor inhibitors will pro-
vide a more precise delineation of the molecular events that
occur in bacterial meningitis. We believe our data provide
evidence for a seminal role of TNF-c i and IL1/3 in the initial
events of meningeal inflammation.
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